Skip to main content
. 2023 Dec 15;15(12):6970–6987.

Table 1.

Sources of exosomes or exosome-like nanovesicles modulating macrophages toward IBD repair

Exosomes/exosome-like nanovesicles source Condition Mechanism Reference
Stem/stromal cell
    Hypoxia-prime adipose-derived stem cells DSS-induced colitis Control the HMGB1/TLR4/NF-κB signaling pathway to cause macrophage M2 polarization. [97]
    Human umbilical cord MSCs DSS-induced colitis Prevent macrophage pyroptosis brought on by casp4 in an inflammatory setting. [31]
    Human bone marrow-derived MSCs DSS/TNBS induced colitis Reduce inflammatory reactions, protects intestinal barrier integrity, polarizes M2b macrophages, and stimulates the production of IL-10. Primarily affects colonic macrophages. [101]
    Human umbilical cord MSCs DSS-induced colitis Enhance the expression of the IL-10 gene and decreases the infiltration of macrophages, TNF-α, IL-1β, IL-6, iNOS, and IL-7 genes. [96]
    Human umbilical cord MSCs DSS-induced colitis Suppress the release of IL-1β from mouse peritoneal macrophages and considerably lowers the relative expression of NLRP3, ASC, caspase-1, IL-18, and IL-1β in macrophages. [29]
    LbL-MSCs UC Increase M2 macrophages to control inflammation while decreasing M1 macrophages. [98]
    Human menstrual blood DSS-induced colitis Reduce colonic inflammation and polarize M2 macrophages in the colon. [99]
    Bone marrow MSC DSS-induced UC Encourage the polarization of M2-like macrophages, which is indicated by a rise in the M2 marker CD163. Upregulate TGF-β and IL-10 and downregulate TNF-α, CCL-24, TNF-α, VEGF-A, and IFN-γ levels. [100]
Macrophage
    M2 DSS-induced colitis MiR-590-3p, highly concentrated in M2 exosomes, suppresses the production of proinflammatory cytokines such as IL-1β, IL-6, and tumor necrosis factor-α. [49]
    M2 DSS-induced colitis Inhibit IL-1β, IL-6, and IL-17A. Offer protection against colitis produced by DSS, mostly through the CC chemokine 1 (CCL1)/CCR8 axis. [11]
Food
    Turmeric Colitis It increase the M1 phenotype’s transition to M2 macrophages and restores the impaired gut epithelial barrier. [112]
    Ginseng DSS-induced colitis Stimulate the synthesis of anti-inflammatory macrophages while downregulating proinflammatory cytokines in proinflammatory macrophages. [113]
    Spermidine DSS-induced colitis Increase the markers for M2 macrophages while decreasing the markers for M1 macrophages in the inflammatory colons. [115]
    Colostrum DSS-induced UC Stimulate the growth of macrophages and colonic epithelial cells, reduce inflammation by efficiently eliminating ROS, and control the release of immune cytokines. [50]
    Milk DSS-induced UC Reduce the inflammatory response by blocking the activation of the NLRP3 inflammasome and the TLR4-NF-κB signaling pathway. Stop the release of cytokines and macrophage polarization toward a proinflammatory phenotype. [116]
Other exosomes/EVs
    Trichinella spiralis DSS-induced colitis Activate M2 macrophages in the colon and prevent M1 macrophage polarization. [117]
    HEK293T cells Sepsis-induced intestinal damage Minimize systemic inflammation and mortality while promoting M2 polarization by reducing mitochondrial reactive oxygen species (mtROS). [118]
Other immune cells
    G-MDSC DSS-induced colitis The G-MDSC exosome (containing Arg-1) inhibits the delayed-type hypersensitivity response, reduces the growth of CD4+ T cells, and decreases IFN-γ and TNF-α levels. [110]

Abbreviations: ASC, apoptosis-associated speck-like protein containing a caspase recruitment domain; DSS, dextran sulfate sodium; G, granulocytic; HMGB1, high mobility group box 1; IFN-γ, interferon-gamma; IL, interleukin; ILVs, intraluminal vesicles; iNOS, inducible nitric oxide synthase; M, macrophage; MDSC, myeloid-derived suppressor cells; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NLRP3, NOD-like receptor family, pyrin domain-containing 3; ROS, reactive oxygen species; TGF-β, transforming growth factor beta; TLR4, Toll-like receptor 4; TNBS, 2,4,6-trinitrobenzenesulfonic acid solution; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.